Open Access

REVIEW

Technological Innovations in Thyroid Cancer Surgery

Federico Cappellacci^*, Gian Luigi Canu, Stefano Piras, Giacomo Anedda, Pietro Giorgio Calò, Fabio Medas

Department of Surgical Sciences, University of Cagliari, Policlinico Universitario Duilio Casula, Monserrato (CA), 09042, Italy

* Corresponding Author: Federico Cappellacci. Email:

Oncologie 2022, 24(1), 35-50. https://doi.org/10.32604/oncologie.2022.020864

Received 16 December 2021; Accepted 08 February 2022; Issue published 31 March 2022

Abstract

Thyroid cancer is the fifth most common cancer in the USA, with differentiated subtype accounting for more than 95% of neoplasm. Surgery remains the mainstay of treatment, either with lobectomy or total thyroidectomy. In the last decades, many technological innovations have been introduced in this field. The aim of this review is to illustrate the most recent advances regarding the classical surgical approach, particularly regarding hemostatic devices, parathyroid identification with fluorescence systems, intraoperative identification of lymph node metastases, and intraoperative neuromonitoring.

---

Keywords

---